150 related articles for article (PubMed ID: 15012776)
1. p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy.
Anzola M; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo M; Burgos JJ
J Gastroenterol Hepatol; 2004 Apr; 19(4):397-405. PubMed ID: 15012776
[TBL] [Abstract][Full Text] [Related]
2. P14ARF gene alterations in human hepatocellular carcinoma.
Anzola M; Cuevas N; López-Martínez M; Saiz A; Burgos JJ; Martínez de Pancorboa M
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):19-26. PubMed ID: 15095848
[TBL] [Abstract][Full Text] [Related]
3. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
4. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC
Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830
[TBL] [Abstract][Full Text] [Related]
5. p16 is a major inactivation target in hepatocellular carcinoma.
Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
[TBL] [Abstract][Full Text] [Related]
6. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
8. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
9. Frequent allelic loss on chromosome 9 in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Lau WY; Hin LY; Lim BK; Lai PB; Chan JY; Wang XQ; Wu S; Lee JC
Int J Cancer; 1999 May; 81(3):319-24. PubMed ID: 10209942
[TBL] [Abstract][Full Text] [Related]
10. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
13. Two distinct pathways of p16 gene inactivation in gallbladder cancer.
Tadokoro H; Shigihara T; Ikeda T; Takase M; Suyama M
World J Gastroenterol; 2007 Dec; 13(47):6396-403. PubMed ID: 18081229
[TBL] [Abstract][Full Text] [Related]
14. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
15. Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma.
Chu HJ; Heo J; Seo SB; Kim GH; Kang DH; Song GA; Cho M; Yang US
J Korean Med Sci; 2004 Feb; 19(1):83-6. PubMed ID: 14966347
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
17. Infrequent alterations of the p16INK4A gene in liver cancer.
Kita R; Nishida N; Fukuda Y; Azechi H; Matsuoka Y; Komeda T; Sando T; Nakao K; Ishizaki K
Int J Cancer; 1996 Jul; 67(2):176-80. PubMed ID: 8760583
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.
Bazan V; Zanna I; Migliavacca M; Sanz-Casla MT; Maestro ML; Corsale S; Macaluso M; Dardanoni G; Restivo S; Quintela PL; Bernaldez R; Salerno S; Morello V; Tomasino RM; Gebbia N; Russo A
J Cell Physiol; 2002 Sep; 192(3):286-93. PubMed ID: 12124774
[TBL] [Abstract][Full Text] [Related]
19. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
[TBL] [Abstract][Full Text] [Related]
20. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
